XBiotech (XBIT) Catches Eye: Stock Adds 5.6% in Session

Zacks

XBiotech, Inc. XBIT was a big mover last session, as its shares rose almost 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. Friday’s rally continues the uptrend for the company since Jun 10, as the stock is now up over 10%.

Over the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Friday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

XBiotech has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

Another favorably ranked stock in the biomedical space is ANI Pharmaceuticals, Inc. ANIP, sporting a Zacks Rank #1 (Strong Buy).

Is XBIT going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research

Be the first to comment

Leave a Reply